Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors

被引：29

作者：

Huang, He ^{[2
]}

Jia, Qi ^{[1
]}

Ma, Jingui ^{[2
]}

Qin, Guangrong ^{[2
]}

Chen, Yingyi ^{[1
]}

Xi, Yonghua ^{[1
]}

Lin, Liping ^{[2
]}

Zhu, Weiliang ^{[2
]}

Ding, Jian ^{[2
]}

Jiang, Hualiang ^{[2
]}

Liu, Hong ^{[2
]}

机构：

[1] Shanghai Univ Tradit Chinese Med, Sch Chinese Med, Shanghai 201203, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 44卷 / 05期

基金：

中国国家自然科学基金;

关键词：

Quercetin; Amino acid; Src; EGFR; Inhibitor; QUERCETIN; GROWTH;

D O I：

10.1016/j.ejmech.2008.09.051

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Quercetin-3-O-amino acid-esters, a new type of quercetin derivatives, were successfully prepared for the first time. Different from quercetin, the novel compounds show higher selectivity as inhibitors against Src tyrosine kinase (IC50 values ranging from 3.2 mu M to 9.9 mu M) than against EGFR tyrosine kinase. Molecular docking reveals that both hydrophobic and hydrogen bonding interactions are important to the selectivity. Therefore, this study provides a new promising scaffold for further development of new anticancer drugs targeting Src tyrosine kinase. (C) 2008 Elsevier Masson SAS. All rights reserved.

引用

页码：1982 / 1988

页数：7

共 35 条

[1] Discovery of a benzotriazine scaffold as a new class of novel src kinase inhibitors
Wrasidlo, W
Dneprovskaia, E
Gong, X
Noronha, G
Hood, J
Barrett, K
Soll, R
Li, G
Liao, W
Zhou, Y
Pathak, VP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2733 - U2734
[2] Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src
Plé, PA
Green, TP
Hennequin, LF
Curwen, J
Fennell, M
Allen, J
Lambert-van der Brempt, C
Costello, G
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (04) : 871 - 887
[3] Metronidazole acid acyl sulfonamide: A novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors
Luo, Yin
Li, Yao
Qiu, Ke-Ming
Lu, Xiang
Fu, Jie
Zhu, Hai-Liang
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (20) : 6069 - 6076
[4] MEDI 114-3-Amino benzo[d]isoxazoles as novel multitargeted receptor tyrosine kinase inhibitors
Ji, Zhiqin
Ahmed, Asma A.
Albert, Daniel H.
Bouska, Jennifer J.
Bousquet, Peter F.
Cunha, George A.
Glaser, Keith B.
Johnson, Eric F.
Guo, Jun
Li, Junling
Marcotte, Patrick A.
Moskey, Maria D.
Pease, Lori J.
Soni, Nirupama B.
Stewart, Kent D.
Tapang, Paul
Yates, Melinda S.
Davidsen, Steven K.
Michaelides, Michael R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[5] SYNTHESIS OF [[(NAPHTHALENYLMETHOXY)PHENYL]AMINO]OXOALKANOIC AND [[(QUINOLINYLMETHOXY)PHENYL]AMINO]OXOALKANOIC ACID-ESTERS - A NOVEL SERIES OF LEUKOTRIENE-D4 ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS
MUSSER, JH
KUBRAK, DM
CHANG, J
LEWIS, AJ
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (08) : 1429 - 1435
[6] Identification of amino acid residues required for a specific interaction between Src-tyrosine kinase and proline-rich region of phosphatidylinositol-3' kinase
Mak, P
He, ZQ
Kurosaki, T
FEBS LETTERS, 1996, 397 (2-3) : 183 - 185
[7] Design, Structure-Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors
Renhowe, Paul A.
Pecchi, Sabina
Shafer, Cynthia M.
Machajewski, Timothy D.
Jazan, Elisa M.
Taylor, Clarke
Antonios-McCrea, William
McBride, Christopher M.
Frazier, Kelly
Wiesmann, Marion
Lapointe, Gena R.
Feucht, Paul H.
Warne, Robert L.
Heise, Carla C.
Menezes, Daniel
Aardalen, Kimberly
Ye, Helen
He, Molly
Le, Vincent
Vora, Jayesh
Jansen, Johanna M.
Wernette-Hammond, Mary Ellen
Harris, Alex L.
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) : 278 - 292
[8] Identification of 7-phenylaxaminothieno[3,2-b]pyridine-6-carbonitriles as a new class of Src kinase inhibitors
Boschelli, DH
Wu, BQ
Sosa, ACB
Durutlic, H
Ye, F
Raifeld, Y
Golas, JM
Boschelli, F
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) : 6666 - 6668
[9] Synthesis, Biological, and Computational Evaluation of Novel 1,3,5-Substituted Indolin-2-one Derivatives as Inhibitors of Src Tyrosine Kinase
Kilic-Kurt, Zuhal
Bakar, Filiz
Olgen, Sureyya
ARCHIV DER PHARMAZIE, 2015, 348 (10) : 715 - 729
[10] A Novel Dual Class III/Src Family Tyrosine Kinase Inhibitor Is Highly Active Against FLT3-ITD Leukemia Cells In Vivo
Muchova, Tereza Radosova
Reznickova, Eva
Somikova, Zuzana
Gucky, Tomas
Strnad, Miroslav
Krystof, Vladimir
Divoky, Vladimir
BLOOD, 2016, 128 (22)

← 1 2 3 4 →